Omnicare, Inc., continues to defend a consolidated shareholder derivative lawsuit pending in Kentucky, according to the Company’s October 25, 2011, Form 10-Q filing with the U.S. Securities and Exchange Commission for the quarter ended September 30, 2011.
On February 13, 2006,…
Reynolds American Inc. is awaiting a court decision on its and other plaintiffs’ appeal from the District Court’s order granting summary judgment, according to the Company’s August 8, 2011, Form 10-Q filing with the U.S. Securities and Exchange Commission for…
Humana Inc. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that the company’s TRICARE South Region contract is under objection from an unsuccessful bidder.
On February 25, 2011, the Department of Defense…
Omnicare, Inc. says that it will continue to pursue an appeal vigorously and seek reversal of the summary judgment on the antitrust and fraud action entitled Omnicare, Inc. v. UnitedHealth Group, Inc., et al., 2:06-cv-00103-WOB.
On May 18, 2006, the action…
Omnicare, Inc. says that the Company has until September 29, 2009, to answer or respond to the qui tam complaint filed by Bernard Lisitza alleging violations of the False Claims Act.
On October 30 and 31, 2008, Omnicare was provided with…
Omnicare, Inc. says that the Company has until September 29, 2009, to answer or respond to the qui tam complaint filed by Deborah Maguire alleging violations of the False Claims Act.
On October 27, 2008, the U.S. District Court in Boston,…
Omnicare, Inc. says that on or about June 24, 2009, the Company reached an agreement in principle, without admitting liability, with the U.S. Attorney s Office, District of Massachusetts, pursuant to which it would pay US$98 million plus interest from…
Omnicare, Inc. says that the Company has until September 29, 2009, to answer or respond to the qui tam complaint filed by David Kammerer alleging violations of the False Claims Act.
On October 30 and 31, 2008, Omnicare was provided with…
Micron Technology Inc. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that the Company and other Dynamic Random Access Memory (DRAM) manufacturers continue to face antitrust law violations suits filed through…
Fresenius Kabi Pharmaceuticals Holding, Inc. faces 22 personal injury/product liability actions (out of an original 34, of which 12 have been dismissed) over local anesthetics like Sensorcaine.
The cases were brought against the Company and other pharmaceutical companies and medical device…